Search clinical trials for: Annexin A5

Total 74 results

Breath of Life International Pharma Ltd

Completed

A Phase I Open Label Study to Assess PK and Safety of Plant Cannabis Extract

Healthy

Israel
University of Barcelona

Completed

Masticatory Side Change and Masticatory Function.

Chewing Problem | Mastication Disorder

Spain
University Hospital Heidelberg
Kieser Training Offenbach / Marko Babovic; Kieser Training AG Zürich / Dr....

Active, not recruiting

Effects of Kieser Resistance Training Plus Kieser Pelvic Floor Training vs. Kieser Resistance Training Plus Traditional Pelvic Floor Exercise on Urinary Incontinence in Prostate Cancer Patients After Radical Prostatectomy (RECON)

Prostate Cancer | Pelvic Floor Disorders | Incontinence, Urinary | Prostate Ectomy

Germany
Radboud University Medical Center

Completed

Rosuvastatin and Ischemia Reperfusion

Ischemia

Netherlands
Boehringer Ingelheim

Completed

Bioequivalence Study of Telmisartan Between T80/A5/H12.5 mg FDC Tablet and T80/A5 mg Tab and H12.5 mg Tab Concomitant Use

Healthy

Japan
Lawson Health Research Institute
London Health Sciences Foundation; Ontario Ministry of Colleges and Universities

Recruiting

Annexin A5 in Patients With Severe COVID-19 Disease (AX-COVID)

Coronavirus Infection | Sepsis

Canada
Radboud University Medical Center
Dutch Diabetes Fund

Completed

Ischemic Injury and Ischemic Preconditioning in Diabetes

Diabetes Mellitus, Insulin-Dependent | Ischemia-Reperfusion Injury

Netherlands
Hospital for Special Surgery, New York
Montefiore Medical Center

Completed

Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus | Antiphospholipid Syndrome | Thrombophilia Due to Antiphospholipid Antibody

United States
Merck Sharp & Dohme LLC

Completed

MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356)

Hypertension
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

The Influence of the 34C>T Variant in the AMPD1 Gene Ischemic Tolerance

AMPD | Ischemic Tolerance
Institut National de la Santé Et de la Recherche...
Advanced Accelerator Applications

Terminated

Assessment of Radiolabeled rhAnnexin V-128 in Infective Endocarditis (AnnIE)

Thrombosis | Endocarditis

France
University Medical Center Groningen

Recruiting

NIR Fluorescence Molecular Imaging of ANXV-800CW in RVO Patients (SIGHT)

Retinal Vein Occlusion

Netherlands
Boehringer Ingelheim

Completed

Comparison in Japan T80/A5 (Telmisartan 80 mg and Amlodipine 5 mg) and T40/A5 (Telmisartan 40 mg and Amlodipine 5 mg)

Hypertension

Japan
Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Recruiting

SY-005 （Recombinant Human Annexin A5）in Patients With Sepsis

Sepsis

China
Radboud University Medical Center

Completed

Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?

Atherosclerosis | Ischemia-Reperfusion Injury

Netherlands
Radboud University Medical Center
GlaxoSmithKline

Completed

The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy.

Ischemia-Reperfusion Injury | The Metabolic Syndrome

Netherlands
Radboud University Medical Center

Withdrawn

Effect of Ischemic Postconditioning on Targeting of Annexin A5 After Forearm Exercise

Cardiovascular Disease | Ischemia-reperfusion Injury | Postconditioning

Netherlands
Boehringer Ingelheim

Completed

An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combinations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 Monotherapy

Hypertension

China, Malaysia, Philippines
Radboud University Medical Center

Suspended

Opioid Receptors Influence Ischemia-Reperfusion Injury

Ischemia-Reperfusion Injury

Netherlands
Pharmacotherapies for Alcohol and Substance Use...
United States Department of Defense; RTI International

Terminated

Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD

Post Traumatic Stress Disorder | Alcohol Abuse

United States
Mitsubishi Tanabe Pharma Corporation

Completed

Monotherapy Study of MP-513 in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Japan
Assistance Publique - Hôpitaux de Paris

Withdrawn

99m Tc-ANNexin-V-128 Scintigraphy for the Identification of Complicated Carotid Atherosclerotic Plaques (ANNICA)

Carotid Atherosclerosis | Atherosclerotic Plaque
Annexin Pharmaceuticals AB

Completed

First in Human Study of ANXV (Recombinant Human Annexin A5) in Healthy Volunteers

Healthy

Netherlands
Boehringer Ingelheim

Completed

To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension

Hypertension

Japan
Mitsubishi Tanabe Pharma Corporation
Vertex Pharmaceuticals Incorporated

Completed

A Phase 1 Study of MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis C

Hepatitis C

Japan
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

The Effect of Caffeine on Ischemic Preconditioning

Caffeine | Ischemia-Reperfusion Injury | Ischemic Preconditioning

Netherlands
Mitsubishi Tanabe Pharma Corporation

Completed

Long-Term Study of MP-214 in Patients With Schizophrenia

Schizophrenia

Taiwan, Korea, Republic of, Japan
Aga Khan University
University of Helsinki; International Diabetes Federation

Unknown

(Pakistan Diabetes Prevention Program PDPP) (PDPP)

Prediabetic State & High Risk Individuals

Pakistan
Annexin Pharmaceuticals AB
InFocus Clinical Research

Recruiting

Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion

Retinal Vein Occlusion

United States
Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Completed

Single-dose/Multiple-doses Incremental Intravenous Injection of SY-005 （Recombinant Human Annexin A5）in Healthy Subjects

Sepsis

China
Boehringer Ingelheim

Completed

Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant Use

Healthy

Japan
Nathan Kline Institute for Psychiatric Research
National Institute of Mental Health (NIMH)

Completed

Safety and Effectiveness of D-serine in Schizophrenia

Schizophrenia

United States
Weill Medical College of Cornell University
National Institute of Mental Health (NIMH)

Completed

Effectiveness of Flutamide in Treating Women With Premenstrual Dysphoric Disorder

Premenstrual Syndrome
Veterans Medical Research Foundation
National Institute of Mental Health (NIMH)

Completed

Side Effects of Newer Antipsychotics in Older Adults

Schizophrenia | Dementia | Alzheimer's Disease

United States
University of Chicago
National Institute of Mental Health (NIMH)

Completed

A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder

Intermittent Explosive Disorder

United States
University of Pennsylvania
National Institute of Mental Health (NIMH)

Completed

Effects of Cognitive Behavioral Therapy on Brain Serotonin Activity in People With Depression

Depression

United States
Medical University of South Carolina
National Institute of Mental Health (NIMH)

Completed

Magnetic Brain Stimulation for the Treatment of Adult Depression

Depression

United States
Georgetown University
National Institute of Mental Health (NIMH); Washington D.C. Veterans Affairs...

Completed

Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia (STAR-1)

Schizophrenia

United States
Massachusetts General Hospital
National Institute of Mental Health (NIMH)

Completed

Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia

Schizophrenia

United States
Lindner Center of HOPE
National Institute of Mental Health (NIMH); University of California, Los Angeles and other collaborators

Completed

Bipolar II Depression: Lithium, SSRI, or the Combination

Depression | Bipolar Disorder

United States
Cedars-Sinai Medical Center
National Institute of Mental Health (NIMH); Massachusetts General Hospital

Completed

Omega-3 Fatty Acids for Treating Adults With Major Depression

Depression

United States
University of Florida
National Institute of Mental Health (NIMH)

Completed

Deep Brain Stimulation for Treatment-Resistant Obsessive Compulsive Disorder

Obsessive-Compulsive Disorder

United States
Coloplast A/S

Completed

Investigating the Safety and Performance of a New 2-piece Ostomy Product Compared With SenSura Click 2-piece

Ileostomy - Stoma

Belgium, Denmark, Norway, Netherlands, Sweden
Digna Biotech S.L.

Completed

A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C

Chronic Hepatitis C Virus Infection | Genotype 1 | Treatment-Experienced Patients | Relapses

Spain
University of Colorado, Denver

Completed

Safety and Effectiveness of Taking Choline Supplements During Pregnancy for Improving Infant Brain Development

Pregnancy | Child Development

United States
Veterans Medical Research Foundation
National Institute of Mental Health (NIMH)

Completed

Examining the Effects of Antipsychotic Medications on Insulin Sensitivity

Diabetes

United States
University of Michigan
National Institute of Mental Health (NIMH)

Completed

Examining Risk Factors for Atypical Antipsychotic Metabolic Side Effects

Schizophrenia

United States
Eisai Inc.

Completed

A Study to Evaluate the Effects of Diltiazem, a Moderate CYP3A4/A5 Inhibitor, on the Pharmacokinetics and Pharmacodynamics of E5555 and Its Metabolites in Healthy Subjects

Healthy Subjects

Netherlands
Yale University
National Institute of Mental Health (NIMH)

Completed

Transcranial Magnetic Stimulation for "Voices"

Schizophrenia | Hallucinations

United States
Yale University
National Institute of Mental Health (NIMH)

Completed

Repetitive Transcranial Magnetic Stimulation for "Voices"

Schizophrenia

United States

Search clinical trials for: Annexin A5

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations